21
views
0
recommends
+1 Recommend
1 collections
    0
    shares

      International Journal of COPD (submit here)

      This international, peer-reviewed Open Access journal by Dove Medical Press focuses on pathophysiological processes underlying Chronic Obstructive Pulmonary Disease (COPD) interventions, patient focused education, and self-management protocols. Sign up for email alerts here.

      39,063 Monthly downloads/views I 2.893 Impact Factor I 5.2 CiteScore I 1.16 Source Normalized Impact per Paper (SNIP) I 0.804 Scimago Journal & Country Rank (SJR)

      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      The Construction of Primary Screening Model and Discriminant Model for Chronic Obstructive Pulmonary Disease in Northeast China

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Objective

          The diagnosis of chronic obstructive pulmonary disease (COPD) is challenging, especially in the primary institution which lacks spirometer. To reduce the rate of COPD missed diagnoses in Northeast China, which has a higher prevalence of COPD, this study aimed to establish efficient primary screening and discriminant models of COPD in this region.

          Patients and Methods

          Subjects from Northeast China were enrolled from December 2017 to April 2019 from The First Hospital of China Medical University. Pulmonary function tests and questionnaire were given to all participants. Using illness or no illness as the goal for screening models and disease severity as the goal for discriminant models, multivariate linear regression, logical regression, linear discriminant analysis, K-nearest neighbor, decision tree and support vector machine were constructed through R language and Python software. After comparing effectiveness among them, the most optimal primary screening and discriminant models were established.

          Results

          Enrolled were 232 COPD patients (124 GOLD I–II and 108 GOLD III–IV) and 218 normal controls. Eight primary screening models were established. The optimal model was Y = −1.2562–0.3891X 4 (education level) + 1.7996X 5 (dyspnea) + 0.5102X 6 (cooking fuel grade) + 1.498X 7 (smoking index) + 0.8077X 9 (family history)-0.5552X 11 (BMI) + 0.538X 13 (cough with sputum) + 2.0328X 14 (wheezing) + 1.3378X 16 (farmers) + 0.8187X 17 (mother’s smoking exposure history during pregnancy)-0.389X 18 (kitchen ventilation) + 0.6888X 19 (childhood heating). Six discriminant models were established. The optimal model was decision tree (the optimal variables: dyspnea (x 5), cooking fuel grade (x 6), second-hand smoking index (x 8), BMI (x 11), cough (x 12), cough with sputum (x 13), wheezing (x 14), farmer (x 16), kitchen ventilation (x 18), and childhood heating (x 19)). The code was established to combine the discriminant model with computer technology.

          Conclusion

          Many factors were related to COPD in Northeast China. Stepwise logistic regression and decision tree were the optimal screening and discriminant models for COPD in this region.

          Most cited references17

          • Record: found
          • Abstract: found
          • Article: not found

          Tiotropium in Early-Stage Chronic Obstructive Pulmonary Disease

          Patients with mild or moderate chronic obstructive pulmonary disease (COPD) rarely receive medications, because they have few symptoms. We hypothesized that long-term use of tiotropium would improve lung function and ameliorate the decline in lung function in patients with mild or moderate COPD.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Prediction models for exacerbations in patients with COPD

            Personalised medicine aims to tailor medical decisions to the individual patient. A possible approach is to stratify patients according to the risk of adverse outcomes such as exacerbations in chronic obstructive pulmonary disease (COPD). Risk-stratified approaches are particularly attractive for drugs like inhaled corticosteroids or phosphodiesterase-4 inhibitors that reduce exacerbations but are associated with harms. However, it is currently not clear which models are best to predict exacerbations in patients with COPD. Therefore, our aim was to identify and critically appraise studies on models that predict exacerbations in COPD patients. Out of 1382 studies, 25 studies with 27 prediction models were included. The prediction models showed great heterogeneity in terms of number and type of predictors, time horizon, statistical methods and measures of prediction model performance. Only two out of 25 studies validated the developed model, and only one out of 27 models provided estimates of individual exacerbation risk, only three out of 27 prediction models used high-quality statistical approaches for model development and evaluation. Overall, none of the existing models fulfilled the requirements for risk-stratified treatment to personalise COPD care. A more harmonised approach to develop and validate high- quality prediction models is needed to move personalised COPD medicine forward. None of the 27 prediction models for COPD exacerbations appears to be ready to support personalised COPD treatment http://ow.ly/Lq2b302IWRx
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Maternal smoking during pregnancy. Effects on lung function during the first 18 months of life.

              The present investigation evaluated the effects of maternal smoking during pregnancy on the growth of lung function during the first 18 mo of life in 159 infants who were part of a longitudinal study of the effects of maternal smoking on respiratory health. Infant pulmonary function was assessed at 2 to 6 wk of age and at 4 to 6, 9 to 12, and 15 to 18 mo of age by partial expiratory flow-volume curves and helium dilution FRC. Maternal smoking was assessed by standard questionnaire and urine cotinine measurements. Maternal smoking during pregnancy was associated with a reduction of 9.4 +/- 4.3 ml (p = 0.029) for FRC and 33 +/- 12.3 ml/s (p = 0.008) reduction for flow at FRC (VFRC) after controlling for the effects of growth (length). The effect of maternal smoking was greater for female infants than for male infants. At 1 yr female infants exposed in utero were predicted to have a 16% reduction in VFRC compared with 5% for male infants. No sex difference was seen for FRC or VFRC/FRC. Exposure to environmental tobacco smoke in the postnatal period was not significantly related to reduced FRC or VFRC. These data provide further evidence that maternal smoking during pregnancy may play a greater role than postnatal and childhood exposure on the observed effects on lung function in children.
                Bookmark

                Author and article information

                Journal
                Int J Chron Obstruct Pulmon Dis
                Int J Chron Obstruct Pulmon Dis
                COPD
                copd
                International Journal of Chronic Obstructive Pulmonary Disease
                Dove
                1176-9106
                1178-2005
                31 July 2020
                2020
                : 15
                : 1849-1861
                Affiliations
                [1 ]Department of Respiratory and Critical Care Medicine, The First Hospital of China Medical University , Shenyang 110000, People’s Republic of China
                [2 ]Department of Mathematics and Statistics, Xi’an JiaoTong University , Xi’an 710049, People’s Republic of China
                [3 ]Department of Pulmonary and Critical Care Medicine, Zhongshan Hospital, Fudan University , Shanghai 200020, People’s Republic of China
                Author notes
                Correspondence: Wei Wang Email wwbycmu@126.com
                Author information
                http://orcid.org/0000-0002-8096-9780
                Article
                250199
                10.2147/COPD.S250199
                7402867
                fbc1e102-9d14-4ef6-a144-9fbeb3a35bc7
                © 2020 Li et al.

                This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.php).

                History
                : 17 February 2020
                : 12 June 2020
                Page count
                Figures: 3, Tables: 13, References: 28, Pages: 13
                Funding
                Funded by: the National Key Research and Development Program of China
                Funded by: the National Natural Science Foundation of China
                This work was supported by grants from the National Key Research and Development Program of China (No. 2018YFC1313600) _ and from the National Natural Science Foundation of China (No. 81670085).
                Categories
                Original Research

                Respiratory medicine
                chronic obstructive pulmonary disease,screening,discriminant,severity,model
                Respiratory medicine
                chronic obstructive pulmonary disease, screening, discriminant, severity, model

                Comments

                Comment on this article